In addition to the TsB concentration, various other factors need to be taken into consideration, including its rate of increase, the child’s gestational age, the presence of possible neurological symptoms, as well as hyperbilirubinemia neurotoxicity risk factors, counting albumin concentration, sepsis, and significant clinical instability in the previous 24 h [20]. This evidence concerns the gene ALB and Hyperbilirubinemia.